Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hilbert

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Clinical Immunology (Orlando, Fla.)|August 8, 2002
B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patientsWilliam Stohl, Gurtej S Cheema, William S Briggs, et al.
Cytokine|January 9, 2001
BLyS BINDS TO B CELLS WITH HIGH AFFINITY AND INDUCES ACTIVATION OF THE TRANSCRIPTION FACTORS NF-kappaB AND ELF-1P Kanakaraj, T S Migone, B Nardelli, et al.
Blood|January 3, 2001
Synthesis and release of B-lymphocyte stimulator from myeloid cellsB Nardelli, O Belvedere, V Roschke, et al.
Journal of Molecular Recognition : JMR|September 24, 2004
Discovery of high-affinity peptide binders to BLyS by phage displayTony J Fleming, Meena Sachdeva, Marko Delic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseasesViktor Roschke, Svetlana Sosnovtseva, Christopher D Ward, et al.
Journal of Medicinal Chemistry|November 1, 1987
Antiulcer agents. 2. Gastric antisecretory, cytoprotective, and metabolic properties of substituted imidazo[1,2-a]pyridines and analoguesJ J Kaminski, J M Hilbert, B N Pramanik, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2024
Controlling CAR-T cell activity and specificity with synthetic SparX adaptersJustin P Edwards, Jeffrey S Swers, Janine M Buonato, et al.
Blood Cells, Molecules & Diseases|November 27, 1999
Phenotypic characterization of immunomagnetically purified umbilical cord blood CD34+ cellsO Belvedere, C Feruglio, W Malangone, et al.
Mabs|August 7, 2012
Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritisPalanisamy Kanakaraj, Bridget A Puffer, Xiao-Tao Yao, et al.
Science (New York, N.Y.)|July 10, 1999
BLyS: member of the tumor necrosis factor family and B lymphocyte stimulatorP A Moore, O Belvedere, A Orr, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Clinical Immunology (Orlando, Fla.)|August 8, 2002
B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patientsWilliam Stohl, Gurtej S Cheema, William S Briggs, et al.
Cytokine|January 9, 2001
BLyS BINDS TO B CELLS WITH HIGH AFFINITY AND INDUCES ACTIVATION OF THE TRANSCRIPTION FACTORS NF-kappaB AND ELF-1P Kanakaraj, T S Migone, B Nardelli, et al.
Blood|January 3, 2001
Synthesis and release of B-lymphocyte stimulator from myeloid cellsB Nardelli, O Belvedere, V Roschke, et al.
Journal of Molecular Recognition : JMR|September 24, 2004
Discovery of high-affinity peptide binders to BLyS by phage displayTony J Fleming, Meena Sachdeva, Marko Delic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseasesViktor Roschke, Svetlana Sosnovtseva, Christopher D Ward, et al.
Journal of Medicinal Chemistry|November 1, 1987
Antiulcer agents. 2. Gastric antisecretory, cytoprotective, and metabolic properties of substituted imidazo[1,2-a]pyridines and analoguesJ J Kaminski, J M Hilbert, B N Pramanik, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2024
Controlling CAR-T cell activity and specificity with synthetic SparX adaptersJustin P Edwards, Jeffrey S Swers, Janine M Buonato, et al.
Blood Cells, Molecules & Diseases|November 27, 1999
Phenotypic characterization of immunomagnetically purified umbilical cord blood CD34+ cellsO Belvedere, C Feruglio, W Malangone, et al.
Mabs|August 7, 2012
Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritisPalanisamy Kanakaraj, Bridget A Puffer, Xiao-Tao Yao, et al.
Science (New York, N.Y.)|July 10, 1999
BLyS: member of the tumor necrosis factor family and B lymphocyte stimulatorP A Moore, O Belvedere, A Orr, et al.
Pageof 10